You are viewing the site in preview mode

Skip to main content

Table 1 The demographic characteristics of both groups

From: Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes

 

Group 1

(n = 2660)

Group 2

(n = 1511)

Age

67.51 ± 10.4 (40–98)

66.95 ± 10.31(40–95)

Female/ male

1256 (47.2%) /1404 (52.7%)

711 (47.0%) /800 (52.9%)

DME-PDR

1418 (50.3%)

772 (51.0%)

nAMD

928 (34.8%)

534 (35.3%)

RVO

314 (11.8%)

205 (13.5%)

  1. DME: Diabetic macular edema, PDR: Proliferative diabetic retinopathy, nAMD: neovascular age-related macular degeneration, RVO: Retinal vein occlusion